{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:32Z","timestamp":1707524552570},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,15]]},"DOI":"10.7759\/cureus.25016","type":"journal-article","created":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T15:42:40Z","timestamp":1652629360000},"source":"Crossref","is-referenced-by-count":1,"title":["Not a Statin-Induced Myopathy: Metastatic Pancreatic Adenocarcinoma Presenting As Paraneoplastic Myositis"],"prefix":"10.7759","author":[{"given":"Gonca","family":"Ozcan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjiya","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Perosevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-33","article-title":"Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report","volume":"11","author":"Syrios J","year":"2011","unstructured":"Syrios J, Kechagias G, Xynos ID, Gamaletsou MN, Papageorgiou A, Agrogiannis G, Tsavaris N. Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC Gastroenterol. 2011, 11:33. 10.1186\/1471-230X-11-33","journal-title":"BMC Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.100479","article-title":"Evaluation and management of polymyositis","volume":"57","author":"Hunter K","year":"2012","unstructured":"Hunter K, Lyon MG. Evaluation and management of polymyositis. Indian J Dermatol. 2012, 57:371-4. 10.4103\/0019-5154.100479","journal-title":"Indian J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000641","article-title":"The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome","volume":"31","author":"Lu X","year":"2019","unstructured":"Lu X, Peng Q, Wang G. The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome. Curr Opin Rheumatol. 2019, 31:643-9. 10.1097\/BOR.0000000000000641","journal-title":"Curr Opin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2021.1982487","article-title":"Paraneoplastic myopathy in pancreatic cancer: a case report and literature review","volume":"11","author":"Padniewski JJ","year":"2021","unstructured":"Padniewski JJ, Nelson E, Mian I, Laczniak A, Ives S, Nasr R. Paraneoplastic myopathy in pancreatic cancer: a case report and literature review. J Community Hosp Intern Med Perspect. 2021, 11:847-51. 10.1080\/20009666.2021.1982487","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0726-4","article-title":"New myositis classification criteria-what we have learned since Bohan and Peter","volume":"20","author":"Leclair V","year":"2018","unstructured":"Leclair V, Lundberg IE. New myositis classification criteria-what we have learned since Bohan and Peter. Curr Rheumatol Rep. 2018, 20:18. 10.1007\/s11926-018-0726-4","journal-title":"Curr Rheumatol Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan A","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975, 292:403-7. 10.1056\/NEJM197502202920807","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas MC","year":"2020","unstructured":"Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. Sep. 2020, 362:971-82. 10.1016\/s0140-6736(03)14368-1","journal-title":"Lancet. Sep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0169-7","article-title":"Malignancy in myositis","volume":"13","author":"Zahr ZA","year":"2011","unstructured":"Zahr ZA, Baer AN. Malignancy in myositis. Curr Rheumatol Rep. 2011, 13:208-15. 10.1007\/s11926-011-0169-7","journal-title":"Curr Rheumatol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.6092\/1590-8577\/1183","article-title":"Pancreas cancer-associated polymyositis of the legs regressing after cephalic duodenopancreatectomy: case report and review of the literature","volume":"13","author":"Amroun KL","year":"2012","unstructured":"Amroun KL, De Mestier L, Deguelte-Lardiere S, Diebold MD, Bouch\u00e9 O, Kianmanesh R. Pancreas cancer-associated polymyositis of the legs regressing after cephalic duodenopancreatectomy: case report and review of the literature. JOP. 2012, 13:674-6. 10.6092\/1590-8577\/1183","journal-title":"JOP"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"13","author":"Hill CL","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, et al.. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001, 13:96-100. 10.1016\/S0140-6736(00)03540-6","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-associated myositis: clinical features and prognostic signs","volume":"1051","author":"Ponyi A","year":"2005","unstructured":"Ponyi A, Constantin T, Garami M, et al.. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005, 1051:64-71. 10.1196\/annals.1361.047","journal-title":"Ann N Y Acad Sci"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201110002-00574","article-title":"Polymyositis as a paraneoplastic phenomenon of occult pancreatic","volume":"106","author":"Siddiqui S","year":"2011","unstructured":"Siddiqui S, Fiorillo M, Tzeng J, Fowkes M. Polymyositis as a paraneoplastic phenomenon of occult pancreatic. Am J Gastroenterol. 2011, 106:S220.","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-007-0579-6","article-title":"A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer","volume":"17","author":"Kida Y","year":"2007","unstructured":"Kida Y, Maeshima E, Furukawa K, Ichikawa T, Goda M, Ichinose M. A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer. Mod Rheumatol. 2007, 17:262-4. 10.1007\/s10165-007-0579-6","journal-title":"Mod Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96528-not-a-statin-induced-myopathy-metastatic-pancreatic-adenocarcinoma-presenting-as-paraneoplastic-myositis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:18Z","timestamp":1707507318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96528-not-a-statin-induced-myopathy-metastatic-pancreatic-adenocarcinoma-presenting-as-paraneoplastic-myositis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,15]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.25016","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,15]]}}}